Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

NCT03045861 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

NCT00002213 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus

NCT03472326 ·Status: TERMINATED ·Phase: PHASE2

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

NCT00050895 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

NCT00002415 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

NCT02607956 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

NCT00945282 ·Status: COMPLETED ·Phase: PHASE2

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

NCT00298350 ·Status: COMPLETED ·Phase: PHASE2

A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

NCT00242879 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

NCT01309243 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

NCT00959894 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

NCT00006154 ·Status: COMPLETED ·Phase: PHASE3

Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Considered for Future On-demand Peri-exposure HIV Prophylaxis Regimens

NCT03976752 ·Status: COMPLETED ·Phase: PHASE1

Single Dose Escalation Study of GSK2838232 in Healthy Subjects

NCT01802918 ·Status: COMPLETED ·Phase: PHASE1

A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients

NCT00002406 ·Status: COMPLETED ·Phase: PHASE3

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

NCT06214052 ·Status: COMPLETED ·Phase: PHASE2

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

NCT00000912 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

NCT00002218 ·Status: COMPLETED ·Phase: PHASE1

Study of GS-3242 in Participants With HIV-1; Substudy-05

NCT07001319 ·Status: COMPLETED ·Phase: PHASE1

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

NCT00053638 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment

NCT00005118 ·Status: UNKNOWN ·Phase: PHASE2

MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)

NCT05700734 ·Status: WITHDRAWN ·Phase: PHASE1

A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

NCT03234036 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

NCT00105157 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of STP0404 in Adults With HIV-1 Infection

NCT05869643 ·Status: COMPLETED ·Phase: PHASE2